MRI评估接受新辅助化疗乳腺癌患者腋窝淋巴结状态的诊断准确性
该回顾性研究纳入88例接受新辅助化疗的乳腺癌患者,比较基线与化疗后MRI与术后病理淋巴结结果。MRI预测腋窝状态的敏感度为68.85%、特异度为85.71%、总体诊断准确率73.07%。结论认为MRI敏感度和准确率低,阴性MRI不能免除确定性腋窝手术。
要点
- MRI预测腋窝淋巴结状态敏感度仅68.85%,阴性不能排除转移。
- 化疗后异常转为正常腋窝淋巴结(ypN0)的比例为38.8%。
- 淋巴结长短轴比值不是腋窝转移的良好预测指标。
核心结论
- MRI在预测接受新辅助化疗乳腺癌患者腋窝淋巴结状态方面敏感度和诊断准确率低。
- 鉴于MRI腋窝阴性预测值低,阴性MRI不能免除确定性腋窝手术。
- 淋巴结长短轴比值不是腋窝转移的良好预测指标。
研究设计与样本
- 回顾性研究,从医院记录中收集2011年至2016年间88例乳腺癌患者的数据。
- 所有患者均接受基线MRI和新辅助化疗结束时的MRI。
- 影像结果与术后组织病理学淋巴结发现进行比较。
- 患者中位年龄54岁(范围32-77岁)。
诊断标准与关键数值
- MRI预测腋窝状态的敏感度为68.85%,特异度为85.71%,总体诊断准确率为73.07%。
- 基线MRI组织学证实腋窝淋巴结阳性的患者为67例(76.1%)。
- 化疗后异常转为正常腋窝淋巴结(ypN0)的总体转化率为38.8%(67例中26例)。
临床应用与阅片要点
- MRI腋窝阴性时不应据此省略确定性腋窝手术。
- 报告MRI腋窝淋巴结时应谨慎解读阴性结果,结合临床和其他评估。
- 淋巴结长短轴比值不宜作为腋窝转移的预测指标。
局限性
- 回顾性研究设计。
- 样本量有限(88例),来自单中心医院记录。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Axillary lymph node status is an important prognostic factor for breast cancer patients. This study aimed to assess the accuracy of MRI in assessing the axillary nodal status in breast cancer patients receiving neo-adjuvant chemotherapy (NACT).
METHODS: Data were retrospectively collected for 88 patients between 2011 and 2016 from the hospital records. All patients had baseline MRI, followed by the end of neoadjuvant chemotherapy MRI. Patient demographics, cancer type, grade, stage, receptor status, and the number of positive lymph nodes identified on the baseline and preoperative MRI were recorded. The imaging results were compared to post-operative histopathological lymph node findings. The median patient age of the patients was 54 years (32-77 years).
RESULTS: There were 67 (76.1%) patients with histologically proven positive axillary lymph nodes on baseline MRI. The overall conversion from abnormal to normal axillary nodes following chemotherapy (ypN0) was 38.8% (26 patients out of 67). The sensitivity and specificity of MRI for predicting axillary status was 68.85 and 85.71%, respectively, with an overall MRI diagnostic accuracy of 73.07%.
CONCLUSION: MRI has low sensitivity and diagnostic accuracy in predicting axillary nodal status in breast cancer patients receiving neoadjuvant chemotherapy. Given the low NPV of MRI of the axilla, a negative MRI does not obviate the need for definitive axillary surgery.
ADVANCES IN KNOWLEDGE: In its current state, MRI cannot obviate the need for axillary surgery in patients receiving NACT. Long: short axis ratio (L: S) of the axillary lymph node is not a good predictor of axillary metastases.
引用
- Bansal, Jaipal, Wu, et al. Diagnostic accuracy of magnetic resonance imaging to evaluate axillary lymph node status in breast cancer patients receiving neoadjuvant chemotherapy. Br J Radiol. 2023. PMID: 36607272. doi:10.1259/bjr.20220904
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。